z-logo
open-access-imgOpen Access
Periocular capillary hemangioma in 2018: natural course, indications for treatment and therapeutic options
Author(s) -
Carlos Fleitman-Broder
Publication year - 2019
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 2604-1731
DOI - 10.24875/rmoe.m19000065
Subject(s) - course (navigation) , capillary hemangioma , medicine , natural (archaeology) , hemangioma , computer science , surgery , history , engineering , archaeology , aerospace engineering
Capillary hemangiomas are one of the most common benign orbital and eyelid childhood tumors. Many of these tumors do not require treatment because they regress spontaneously without leaving sequelae; however, treatment is necessary in many cases, such as amblyogenic or eye-threatening lesions. Treatment of this kind of lesions has evolved from surgical excision to laser and steroids, all of them successful in different ways and with a range of side effects. In the last few years treatment has been revolutionized due to a casual finding made by Leaute-Labreze et al. Nowadays we use beta-blockers that have proved to be highly effective and with a much safer profile than previously used drugs. Several case reports have shown success by treating these lesions with topical beta-blockers. With this safer and more effective treatment, we can currently

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom